{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T06:13:32Z","timestamp":1762409612823,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.prp.2019.152528","type":"journal-article","created":{"date-parts":[[2019,7,6]],"date-time":"2019-07-06T10:36:43Z","timestamp":1562409403000},"page":"152528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Quantitative proteomics analysis of differentially expressed proteins in activated B-cell-like diffuse large B-cell lymphoma using quantitative proteomics"],"prefix":"10.1016","volume":"215","author":[{"given":"Hai-Xia","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aijiang","family":"Nuerlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulinaer","family":"Abulajiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Li","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Sang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si-Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Ping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prp.2019.152528_bib0005","first-page":"12","article-title":"Diffuse large B-cell lymphoma-treatment approaches in the molecular era, nature reviews","volume":"11","author":"Roschewski","year":"2014","journal-title":"Clin. Oncol."},{"issue":"12","key":"10.1016\/j.prp.2019.152528_bib0010","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.clml.2017.10.007","article-title":"Advances in diagnosis and management of diffuse large B-cell lymphoma","volume":"17","author":"Cabanillas","year":"2017","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"11","key":"10.1016\/j.prp.2019.152528_bib0015","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/j.leukres.2007.03.017","article-title":"The GCB subtype of diffuse large B-cell lymphoma is less frequent in Asian countries","volume":"31","author":"Shiozawa","year":"2007","journal-title":"Leuk. Res."},{"issue":"1","key":"10.1016\/j.prp.2019.152528_bib0020","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1182\/asheducation-2016.1.366","article-title":"Diffuse large B-cell lymphoma: R-CHOP failure-what to do?","volume":"2016","author":"Coiffier","year":"2016","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"issue":"15","key":"10.1016\/j.prp.2019.152528_bib0025","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMra0807082","article-title":"Aggressive lymphomas","volume":"362","author":"Georg","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"32","key":"10.1016\/j.prp.2019.152528_bib0030","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1038\/onc.2015.493","article-title":"Oncogenic CARMA1 couples NF-\u03baB and \u03b2-catenin signaling in diffuse large B-cell lymphomas","volume":"35","author":"Bognar","year":"2016","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.prp.2019.152528_bib0035","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","article-title":"NF-\u03baB, an active player in human cancers","volume":"2","author":"Xia","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"11","key":"10.1016\/j.prp.2019.152528_bib0040","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.clml.2016.08.008","article-title":"Key molecular drivers of chronic lymphocytic leukaemia (CLL)","volume":"16","author":"Alsagaby","year":"2016","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"issue":"9","key":"10.1016\/j.prp.2019.152528_bib0045","doi-asserted-by":"crossref","first-page":"14304","DOI":"10.3390\/molecules190914304","article-title":"Inhibition of the PI3K\/Akt\/mTOR signaling pathway in diffuse large B-cell lymphoma: current knowledge and clinical significance","volume":"19","author":"Agata","year":"2014","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.prp.2019.152528_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpath.2017.04.009","article-title":"Role of AKT hyperactivation and the potential of AKT-Targeted therapy in diffuse large B-cell lymphoma","volume":"187","author":"Wang","year":"2017","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2019.152528_bib0055","doi-asserted-by":"crossref","first-page":"317","DOI":"10.15537\/smj.2019.4.23598","article-title":"Proteomics insights into the pathology and prognosis of chronic lymphocytic leukemia","volume":"40","author":"Alsagaby","year":"2019","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.prp.2019.152528_bib0060","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jprot.2013.08.002","article-title":"Proteomic analysis of B-cell receptor signaling in chronic lymphocytic leukaemia reveals a possible role for kininogen","volume":"91","author":"Kashuba","year":"2013","journal-title":"J. Proteomics"},{"issue":"11","key":"10.1016\/j.prp.2019.152528_bib0065","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1021\/pr5002803","article-title":"Proteomics-based strategies to identify proteins relevant to chronic lymphocytic leukemia","volume":"13","author":"Alsagaby","year":"2014","journal-title":"J. Proteome Res."},{"issue":"2015","key":"10.1016\/j.prp.2019.152528_bib0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/841769","article-title":"SILAC-based quantitative proteomic analysis of diffuse large B-cell lymphoma patients","volume":"2015","author":"R\u00fcetschi","year":"2015","journal-title":"Int. J. Proteomics"},{"issue":"2","key":"10.1016\/j.prp.2019.152528_bib0075","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.cell.2017.09.027","article-title":"Genetic and functional drivers of diffuse large B cell lymphoma","volume":"171","author":"Reddy","year":"2017","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.prp.2019.152528_bib0080","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/prca.201600074","article-title":"Serum protein profiling in diffuse large B-cell lymphoma","volume":"10","author":"Riby","year":"2016","journal-title":"PROTEOMICS \u2013 Clin. Appl."},{"key":"10.1016\/j.prp.2019.152528_bib0085","doi-asserted-by":"crossref","DOI":"10.1159\/000486285","article-title":"Proteomic profiling of diffuse large B-Cell lymphomas","author":"Kwieci\u0144ska","year":"2018","journal-title":"Pathobiol. J. Immunopathol. Mol. Cell. Biol."},{"issue":"15","key":"10.1016\/j.prp.2019.152528_bib0090","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","article-title":"Genetics and pathogenesis of diffuse large B-cell lymphoma","volume":"378","author":"Schmitz","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.prp.2019.152528_bib0095","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1007\/s12032-013-0528-5","article-title":"Identification of differentially expressed proteins in chemotherapy-sensitive and chemotherapy-resistant diffuse large B cell lymphoma by proteomic methods","volume":"30","author":"Liu","year":"2013","journal-title":"Med. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2019.152528_bib0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejca.2014.10.017","article-title":"Differential proteomic analysis of endemic and sporadic Epstein\u2013Barr virus-positive and negative Burkitt lymphoma","volume":"51","author":"El-Mallawany","year":"2015","journal-title":"Eur. J. Cancer"},{"issue":"6","key":"10.1016\/j.prp.2019.152528_bib0105","first-page":"8084","article-title":"iTRAQ-based quantitative proteomic analysis and bioinformatics study of proteins in retinoblastoma","volume":"14","author":"Cheng","year":"2017","journal-title":"Oncol. Lett."},{"issue":"12","key":"10.1016\/j.prp.2019.152528_bib0110","doi-asserted-by":"crossref","first-page":"28566","DOI":"10.3390\/ijms161226120","article-title":"Parallel reaction monitoring: a targeted experiment performed using high resolution and high mass accuracy mass spectrometry","volume":"16","author":"Navin","year":"2015","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.prp.2019.152528_bib0115","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/bjh.12659","article-title":"Differences in incidence and trends of haematological malignancies in Japan and the United States","volume":"164","author":"Dai","year":"2014","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.prp.2019.152528_bib0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2018.03.005","article-title":"Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI","volume":"32","author":"Wight","year":"2018","journal-title":"Blood Rev."},{"issue":"9","key":"10.1016\/j.prp.2019.152528_bib0125","article-title":"Is now the time for molecular driven therapy for diffuse large B-cell lymphoma?","volume":"10","author":"Di","year":"2017","journal-title":"Expert Rev. Hematol."},{"issue":"2","key":"10.1016\/j.prp.2019.152528_bib0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3960\/jslrt.56.71","article-title":"Molecular pathogenesis of diffuse large B-cell lymphoma","volume":"56","author":"Dobashi","year":"2016","journal-title":"J. Clin. Exp. Hematopathol. Jceh"},{"key":"10.1016\/j.prp.2019.152528_bib0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-3-319-13150-4_11","article-title":"Management of diffuse large B-cell lymphoma (DLBCL)","volume":"165","author":"Boris","year":"2015","journal-title":"Cancer Treat. Res."},{"issue":"1","key":"10.1016\/j.prp.2019.152528_bib0140","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1146\/annurev-med-062913-051343","article-title":"The PI3K\/AKT pathway as a target for cancer treatment","volume":"67","author":"Mayer","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.prp.2019.152528_bib0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1158\/1078-0432.28.11.1","article-title":"Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling","volume":"11","author":"Lam","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.prp.2019.152528_bib0150","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.3109\/10428191003802365","article-title":"Leptin receptor expression and its association with PI3K\/AKT signaling pathway in diffuse large B-cell lymphoma","volume":"51","author":"Uddin","year":"2010","journal-title":"Leuk. Lymphoma"},{"issue":"2","key":"10.1016\/j.prp.2019.152528_bib0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11764-009-0111-4","article-title":"Alcohol consumption and non-Hodgkin lymphoma survival","volume":"4","author":"Han","year":"2010","journal-title":"J. Cancer Survivorship Res. Pract."},{"issue":"48","key":"10.1016\/j.prp.2019.152528_bib0160","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/jncimonographs\/lgu010","article-title":"Medical history, lifestyle, family history, and occupational risk factors for diffuse large B-cell lymphoma: the interlymph non-Hodgkin lymphoma subtypes project","volume":"2014","author":"Cerhan","year":"2014","journal-title":"J. Natl. Cancer Inst. Monogr."},{"issue":"7","key":"10.1016\/j.prp.2019.152528_bib0165","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1017\/S1368980013001249","article-title":"Dietary patterns and the risk of non-Hodgkin lymphoma","volume":"17","author":"Ollberding","year":"2014","journal-title":"Public Health Nutr."},{"issue":"2","key":"10.1016\/j.prp.2019.152528_bib0170","first-page":"381","article-title":"Evidence for involvement of NFBP in processing of ribosomal RNA","volume":"214","author":"Thersa","year":"2010","journal-title":"J. Cell. Physiol."},{"issue":"8","key":"10.1016\/j.prp.2019.152528_bib0175","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.181040","article-title":"Telomerase activates transcription of cyclin D1 gene through the interaction with NOL1","volume":"129","author":"Hong","year":"2016","journal-title":"J. Cell. Sci."},{"issue":"2","key":"10.1016\/j.prp.2019.152528_bib0180","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.celrep.2018.03.066","article-title":"Small-molecule targeting of RNA polymerase I activates a conserved transcription elongation checkpoint","volume":"23","author":"Wei","year":"2018","journal-title":"Cell Rep."},{"issue":"16","key":"10.1016\/j.prp.2019.152528_bib0185","doi-asserted-by":"crossref","first-page":"5957","DOI":"10.1128\/MCB.00673-06","article-title":"Casein kinase 2 associates with initiation-competent RNA polymerase I and has multiple roles in ribosomal DNA transcription","volume":"26","author":"Panova","year":"2006","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.prp.2019.152528_bib0190","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/14728222.2012.668185","article-title":"14-3-3 zeta as novel molecular target for cancer therapy","volume":"16","author":"Ajay","year":"2012","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.prp.2019.152528_bib0195","doi-asserted-by":"crossref","DOI":"10.4149\/neo_2018_170922N603","article-title":"Anticancer effect of YWHAZ silencing via inducing apoptosis and autophagy in gastric cancer cells","author":"Guo","year":"2018","journal-title":"Neoplasma"},{"issue":"6","key":"10.1016\/j.prp.2019.152528_bib0200","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/bjc.2013.65","article-title":"Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma","volume":"108","author":"Nishimura","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2019.152528_bib0205","doi-asserted-by":"crossref","first-page":"6555","DOI":"10.1038\/s41598-017-06848-y","article-title":"A single amino acid substitution confers B-cell clonogenic activity to the HIV-1 matrix protein p17","volume":"7","author":"Giagulli","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2019.152528_bib0210","first-page":"177","article-title":"Roles of the NF-\u03baB pathway in B-Lymphocyte biology","volume":"393","author":"Sasaki","year":"2016","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"1","key":"10.1016\/j.prp.2019.152528_bib0215","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/1476-4598-9-228","article-title":"I- kappa -kinase-2 (IKK-2) inhibition potentiates vincristine cytotoxicity in non-Hodgkin\u2019s lymphoma","volume":"9","author":"Al-Katib","year":"2010","journal-title":"Mol. Cancer"},{"issue":"39","key":"10.1016\/j.prp.2019.152528_bib0220","doi-asserted-by":"crossref","first-page":"26960","DOI":"10.1074\/jbc.M114.598763","article-title":"I\u03baB kinase \u03b2 (IKBKB) mutations in lymphomas that constitutively activate canonical nuclear factor \u03baB (NF\u03baB) signaling","volume":"289","author":"Xin","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.prp.2019.152528_bib0225","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4155\/ppa.13.31","article-title":"Small-molecule inhibitors of IkappaB kinase (IKK) and IKK-related kinases","volume":"2","author":"Llona-Minguez","year":"2013","journal-title":"Pharm. Pat. Anal."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819305102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033819305102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:38:25Z","timestamp":1759732705000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033819305102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0344033819305102"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2019.152528","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative proteomics analysis of differentially expressed proteins in activated B-cell-like diffuse large B-cell lymphoma using quantitative proteomics","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2019.152528","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152528"}}